MLICM
IMDX

Metropolitan Life Insurance Company (MetLife)’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio IMDX Stock Details IMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,162
Closed -$133K – 2848
2021
Q2 		$133K Buy
1,162
+134
+13% +$15.4K ﹤0.01% 2433
2021
Q1 		$107K Buy
+1,028
New +$107K ﹤0.01% 2399